# Risk Factors and Long-term Impact of ICIs

> **NCT05754983** · — · ACTIVE_NOT_RECRUITING · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 1000 (estimated)

## Conditions studied

- Malignant Neoplasm

## Interventions

- **DRUG:** Solid tumor patients receiving immunotherapy for the first time were included in the study

## Key facts

- **NCT ID:** NCT05754983
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-11-24
- **Primary completion:** 2024-12-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05754983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05754983, "Risk Factors and Long-term Impact of ICIs". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05754983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*